Defense Spending Surging: MISL vs ITA ETFs for 2026
As defense spending surging reshapes markets, two ETFs—MISL and ITA—offer different paths to ride the trend. This gui...
Choosing between equal and cap weight depends on goals and risk tolerance. This quick guide compares the two for retirement suitability.
24,468 articlesAs defense spending surging reshapes markets, two ETFs—MISL and ITA—offer different paths to ride the trend. This gui...
When a top executive sells stock, investors ask: Is this a red flag or routine planning? This guide breaks down the 9...
As market nerves remain tied to crude prices, the VanEck Energy Income ETF (EINC) continues to offer a solid 3.2%-3.6...
The FDA confirms a national shortage of needles used detect breast after a recall. Hospitals warn the gap could delay...
ARKK charges a 0.75% annual fee that quietly drags returns. This article explains the cost, contrasts with cheaper pe...
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Meta’s AI model outlines multiple XRP price paths for 2026, showing a base target and upside scenarios as ETF demand ...
As MiCA’s July 1 deadline approaches, EU platforms must be MiCA-compliant, while the UK maintains its own FCA framewo...
Investing in eVTOLs isn’t just about flight tech. The real lever could be charging infrastructure. This guide explain...
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Three sector ETFs are beating the Nasdaq tech index in 2026, signaling a shift toward defense tech, electrification, ...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...